Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases
Keun Woo Ryu, Dae-Seok Kim, W. Lee Kraus
Chemical Reviews (2015) Vol. 115, Iss. 6, pp. 2453-2481
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Rebecca Gupte, Ziying Liu, W. Lee Kraus
Genes & Development (2017) Vol. 31, Iss. 2, pp. 101-126
Open Access | Times Cited: 618
Transcriptional regulation of hepatic lipogenesis
Yuhui Wang, José A. Viscarra, Sun-Joong Kim, et al.
Nature Reviews Molecular Cell Biology (2015) Vol. 16, Iss. 11, pp. 678-689
Open Access | Times Cited: 585
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 403
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Jennine M. Dawicki-McKenna, Marie-France Langelier, Jamie E. DeNizio, et al.
Molecular Cell (2015) Vol. 60, Iss. 5, pp. 755-768
Open Access | Times Cited: 301
The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA repair (2018) Vol. 71, pp. 177-182
Open Access | Times Cited: 299
ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease
Bernhard Lüscher, Mareike Bütepage, Laura Eckei, et al.
Chemical Reviews (2017) Vol. 118, Iss. 3, pp. 1092-1136
Closed Access | Times Cited: 223
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21
Dae-Seok Kim, Cristel V. Camacho, Anusha Nagari, et al.
Molecular Cell (2019) Vol. 75, Iss. 6, pp. 1270-1285.e14
Open Access | Times Cited: 213
Metabolic regulation of transcription through compartmentalized NAD + biosynthesis
Keun Woo Ryu, Tulip Nandu, Jiyeon Kim, et al.
Science (2018) Vol. 360, Iss. 6389
Open Access | Times Cited: 212
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
Tiziana Annese, Roberto Tamma, Michelina De Giorgis, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 211
An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
Ying-Qing Wang, Pingyuan Wang, Yu-Ting Wang, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 21, pp. 9575-9598
Closed Access | Times Cited: 200
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Nathan A. Berger, Valérie C. Besson, A. Hamid Boulares, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 2, pp. 192-222
Open Access | Times Cited: 193
Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9
Chunsong Yang, Kasey Jividen, Adam Spencer, et al.
Molecular Cell (2017) Vol. 66, Iss. 4, pp. 503-516.e5
Open Access | Times Cited: 191
The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions
Anthony R. Fehr, Sasha A. Singh, Catherine M. Kerr, et al.
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 341-359
Open Access | Times Cited: 188
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Dan Huang, W. Lee Kraus
Molecular Cell (2022) Vol. 82, Iss. 12, pp. 2315-2334
Open Access | Times Cited: 158
PARPs and ADP-Ribosylation: 50 Years … and Counting
W. Lee Kraus
Molecular Cell (2015) Vol. 58, Iss. 6, pp. 902-910
Open Access | Times Cited: 166
PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis
Dae-Seok Kim, Sridevi Challa, Aarin Jones, et al.
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 302-320
Open Access | Times Cited: 122
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
Gianluca Papeo, Helena Posteri, Daniela Borghi, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 17, pp. 6875-6898
Closed Access | Times Cited: 121
PARPs in lipid metabolism and related diseases
Magdolna Szántó, Rebecca Gupte, W. Lee Kraus, et al.
Progress in Lipid Research (2021) Vol. 84, pp. 101117-101117
Open Access | Times Cited: 102
The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
Yueshuang Ke, Chenxin Wang, Jiaqi Zhang, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1047-1047
Open Access | Times Cited: 100
PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity
Xin Luo, Keun Woo Ryu, Dae-Seok Kim, et al.
Molecular Cell (2017) Vol. 65, Iss. 2, pp. 260-271
Open Access | Times Cited: 96
PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions
Giuliana Catara, Giovanna Grimaldi, Laura Schembri, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 93
PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
Lotte van Beek, Éilís McClay, Saleha Patel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5112-5112
Open Access | Times Cited: 68
NAD metabolism: Role in senescence regulation and aging
Claudia C.S. Chini, Heidi Soares Cordeiro, Ngan Tran, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 36
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 9
Single-cell Rapid Capture Hybridization sequencing to reliably detect isoform usage and coding mutations in targeted genes
Hongke Peng, Jafar S. Jabbari, Luyi Tian, et al.
Genome Research (2025), pp. gr.279322.124-gr.279322.124
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top